nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of hospital-based charges following partial and radical nephrectomy
|
McKiernan, J.M |
|
2002 |
7 |
1 |
p. 3-6 4 p. |
artikel |
2 |
Ethical issues in the use of tumor markers in clinical investigation of the management of bladder cancer
|
McCullough, Laurence B. |
|
2002 |
7 |
1 |
p. 35-37 3 p. |
artikel |
3 |
Expression of CD44 protein in renal cell carcinomas
|
Zolota, Vassiliki |
|
2002 |
7 |
1 |
p. 13-17 5 p. |
artikel |
4 |
Genetic fieldwork for hereditary prostate cancer studies
|
Plaetke, Rosemarie |
|
2002 |
7 |
1 |
p. 19-27 9 p. |
artikel |
5 |
Introduction to the special section on the ethics of marker tumors in clinical investigation
|
Lerner, Seth P. |
|
2002 |
7 |
1 |
p. 29- 1 p. |
artikel |
6 |
Outcome research
|
Moul, Judd W. |
|
2002 |
7 |
1 |
p. 39-42 4 p. |
artikel |
7 |
Overview of Contents
|
Prout Jr., George R. |
|
2002 |
7 |
1 |
p. 1-2 2 p. |
artikel |
8 |
The clinical role of prostate-specific membrane antigen (PSMA)
|
Chang, Sam S. |
|
2002 |
7 |
1 |
p. 7-12 6 p. |
artikel |
9 |
The use of the marker tumor concept in Ta, T1 bladder cancer
|
van der Meijden, Adrian P.M. |
|
2002 |
7 |
1 |
p. 31-33 3 p. |
artikel |